Pasithea Therapeutics Corp. (KTTAW) FCF Margin (2022)

Pasithea Therapeutics has disclosed FCF Margin across 1 years of filings, most recently posting 1361.84% for Q4 2022.

• In Q4 2022, FCF Margin changed N/A year-over-year to 1361.84%; the TTM figure through Dec 2022 stood at 2466.64% (changed N/A YoY), while the FY2022 annual figure was 2466.64%, up 1874941.0% from the prior year.
• FCF Margin came in at 1361.84% for Q4 2022 at Pasithea Therapeutics, up from 2116.61% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 1361.84% in Q4 2022 to a low of 15771.77% in Q1 2022.